Dow Up 0.08% Nasdaq Down 0.30%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
1.44 Up 0.09(6.67%) Sep 19, 4:15PM EDT
|After Hours : 1.45 Up 0.01 (0.69%) Sep 19, 7:42PM EDT
Prev Close:1.35
Open:1.35
Bid:1.32 x 19100
Ask:1.47 x 5000
1y Target Est:4.50
Beta:3.76
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:1.34 - 1.47
52wk Range:1.10 - 2.14
Volume:5,025,847
Avg Vol (3m):1,771,750
Market Cap:378.55M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DVAXUp 6.67%378.55M
GSKUp 0.19%113.81B
MRKUp 0.30%174.49B
RHHBYDown 0.70%255.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):28.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :-0.09
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases, and cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback